Heart Failure

View the latest content related to this topic

News

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Usage gaps widened according to patient age and—in the US—by income level. But what level of use implies best care?

Michael O'Riordan

January 22, 2020

Slides

See all

Presentation

Controversies and Advances 2019

Echo imaging in HFpEF

Presenter: Jeroen Bax

November 15, 2019

Presentation

Controversies and Advances 2019

How should we really manage functional mitral regurgitation?

Presenter: Michele Hamilton

November 15, 2019

Presentation

TCT Abstracts Posters 2019

Pressure Sensor Devices in Congestive Heart Failure: An Insight from the Nationwide Readmission Data

Presenter: Kristina Gifft

October 04, 2019

Presentation

TCT Abstracts Posters 2019

Association Between Duration of Beta-blocker Therapy and Clinical Outcomes in Acute Myocardial Infarction Patients Without Heart Failure

Presenter: Jihoon Kim

October 03, 2019

Presentation

TCT 2019

Transcutaneous Pericardictomy for HFpEF

Presenter: Samuel Asirvatham

September 28, 2019

News

See all

News

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

By Michael O'Riordan

January 22, 2020

News • Interventional

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

By Caitlin E. Cox

January 20, 2020

News

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

By Caitlin E. Cox

January 14, 2020

Feature

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

By Michael O'Riordan

January 10, 2020

News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

By Michael O'Riordan

January 03, 2020

CTO 2020

February 20

February 21, 2020

TVT 2020

June 17

June 20, 2020

CHIP Seattle 2019

August 2

August 03, 2019

EuroPCR 2019

May 21

May 24, 2019

SCAI 2019

May 19

May 22, 2019

Videos on This Topic

See all

REGISTER for free or LOG IN to view this content

Become a GOLD or PLATINUM member to access PowerPoint files, presentation audio, and video

September 28, 2019

Advertisement

Heart Failure

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Slides

Echo imaging in HFpEF

How should we really manage functional mitral regurgitation?

Pressure Sensor Devices in Congestive Heart Failure: An Insight from the Nationwide Readmission Data

Association Between Duration of Beta-blocker Therapy and Clinical Outcomes in Acute Myocardial Infarction Patients Without Heart Failure

Transcutaneous Pericardictomy for HFpEF

News

TAVR and Other Advanced CVD Therapies Used Less in Ontario Than NY State

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Heart Failure Itself, Not Just the Hospital Stay, May Raise Long-term VTE Risk

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

More on This Topic

Upcoming Conferences

CTO 2020

TVT 2020

Conference Coverage

CHIP Seattle 2019

EuroPCR 2019

SCAI 2019

Videos on This Topic

REGISTER for free or LOG IN to view this content

Advertisement

Advertisement

Heart Failure

Slides

News

More on This Topic

Upcoming Conferences

Conference Coverage

Videos on This Topic

REGISTER for free or LOG IN to view this content

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content